Cite Filings / CMPX / 0000902664-25-000873

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Compass Therapeutics, Inc. Filed 2025-02-12 Acc 0000902664-25-000873

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-13 4 Options or other derivatives
2025-02-13 4 Options or other derivatives
2025-02-13 4 Options or other derivatives
2025-02-13 4 Options or other derivatives
2025-02-12 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-11 4 CEO gave up 41,687 shares (to pay taxes)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…